Zobrazeno 1 - 10
of 149
pro vyhledávání: '"L M, Bershteĭn"'
Autor:
I G Kovalenko, L M Bershteĭn
Publikováno v:
Problems of Endocrinology. 56:47-51
The current concept of obesity as a heterogeneous condition is discussed. Such interpretation provides a basis for distinguishing a group of obese subjects without metabolic disturbances (metabolically healthy obese (MHO) subjects) and another one in
Publikováno v:
Voprosy onkologii. 60(4)
Metabolism and information between cells is the basis of the existence of any multicellular organism. Malfunction of the intercellular communication play an important and sometimes decisive role in the pathogenesis of the most diseases, including can
Autor:
E V, Tsyrlina, O G, Kriukova, T E, Poroshina, E A, Tyrkevich, N Iu, Barash, Z I, Mullakhmetova, V F, Semiglazov, L M, Bershteĭn
Publikováno v:
Voprosy onkologii. 60(4)
The state of the viscosity of erythrocyte membranes in breast cancer patients (68--in menopause and 32--with menstrual cycle) was studied in comparison with the content of steroid hormone receptors in the tumor tissue and the age of patients. It is s
Autor:
L M, Bershteĭn
Publikováno v:
Voprosy onkologii. 60(3)
Simultaneously with keeping one of the leading positions in the structure of oncogynecological morbidity, endometrial cancer (EC) presents for many decades 'the food for brains' of cancer endocrinologists. Step by step development of contemporary ide
[Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence]
Autor:
N V, Roshchina, E V, Tsyrlina, Iu A, Punanov, S A, Safonova, L M, Bershteĭn, E V, Kostromina, A P, Malinin, E V, Morozova
Publikováno v:
Voprosy onkologii. 60(3)
The paper presents the results of a study of the ovarian reserve in young women who received treatment for malignant tumors in childhood and adolescence and are in complete clinical remission. The function of the reproductive system was evaluated by
Autor:
I M, Kovalenko, L M, Bershteĭn
Publikováno v:
Voprosy onkologii. 60(1)
Frequency of separate malignancies and diabetes tends to an increase. This is one of the reasons that diabetes is more often attracting attention as a potential risk factor for cancer. At the same time, in general, relatively less attention is paid t
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (12)
The group (totally 156 postmenopausal women) used for the study of 'standard' (S) and 'associated' (A) genetic markers of potential sensitivity to metformin (MF) consisted of 37 healthy females, 32--with diabetes (DM) without cancer, 64 cancer patien
Publikováno v:
Voprosy onkologii. 59(6)
Metformin (MF) belongs to the most popular andidiabetic medicines and is considered to possess a selective antineoplastic action. This selectivity at least partly may be explained by the certain features of MF pharmacogenetics. More than 150 postmeno
Autor:
L M, Bershteĭn
Publikováno v:
Voprosy onkologii. 59(3)
Autor:
L M, Bershteĭn, D A, Vasil'ev, M P, Boiarkina, E A, Turkevich, G A, Dashian, T E, Poroshina, E V, Tsyrlina, I M, Kovalenko, O G, Kriukova
Publikováno v:
Voprosy onkologii. 59(3)
Preliminary data are confirmed on the more rare prevalence of family history of diabetes mellitus (DM) in cancer patients, mainly females, with diabetes in comparison with diabetics without cancer pathology. Familial diabetes does not worsen addition